MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market
Holding INKT?
Track your performance easily

MiNK Therapeutics (INKT) Technical Analysis

109 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
MiNK Therapeutics’s (INKT) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting MiNK Therapeutics is a Buy.
MiNK Therapeutics’s (INKT) 20-Day exponential moving average is 0.79, while MiNK Therapeutics’s (INKT) share price is $0.767, making it a Sell.
MiNK Therapeutics’s (INKT) 50-Day exponential moving average is 0.84, while MiNK Therapeutics’s (INKT) share price is $0.767, making it a Sell.

MiNK Therapeutics (INKT) Pivot Points

Sep 20, 2024, 02:40 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.72
0.73
0.74
0.76
0.77
0.78
0.79
Fibonacci
0.73
0.74
0.75
0.76
0.77
0.77
0.78
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MiNK Therapeutics (INKT) Moving Averages

Sep 20, 2024, 02:40 AM
Period
Simple
Exponential
MA5
0.76Sell
0.76Sell
MA10
0.77Sell
0.77Sell
MA20
0.79Sell
0.79Sell
MA50
0.86Sell
0.84Sell
MA100
0.90Sell
0.88Sell
MA200
0.93Sell
0.93Sell
MiNK Therapeutics’s (INKT) 10-Day exponential moving average is 0.77, while MiNK Therapeutics’s (INKT) share price is $0.767, making it a Sell.
MiNK Therapeutics’s (INKT) 100-Day exponential moving average is 0.88, while MiNK Therapeutics’s (INKT) share price is $0.767, making it a Sell.
MiNK Therapeutics’s (INKT) stock price is $0.767 and MiNK Therapeutics’s (INKT) 50-day simple moving average is 0.86, creating a Sell signal.
MiNK Therapeutics’s (INKT) stock price is $0.767 and MiNK Therapeutics’s (INKT) 100-day simple moving average is 0.90, creating a Sell signal.
MiNK Therapeutics’s (INKT) stock price is $0.767 and MiNK Therapeutics’s (INKT) 200-day simple moving average is 0.93, creating a Sell signal.

MiNK Therapeutics (INKT) Technical Indicators

Sep 20, 2024, 02:40 AM
Name
Value
Implied Action
RSI (14)
35.88
Neutral
STOCH (9,6)
14.95
Buy
STOCHRSI (14)
14.95
Buy
MACD (12,26)
-0.03
Buy
ADX (14)
18.03
Buy
Williams %R
-76.42
Buy
CCI (14)
-207.71
Buy
ATR (14)
0.04
-
Ultimate Oscillator
38.59
Neutral
ROC
-6.33
Sell
MiNK Therapeutics’s (INKT) Relative Strength Index (RSI) is 35.88, creating a Neutral signal.
MiNK Therapeutics’s (INKT) Trend Strength Indicator (ADX) is 18.03, creating a Buy signal.
MiNK Therapeutics’s (INKT) Commodity Channel Index (CCI) is -207.71, creating a Buy signal.
MiNK Therapeutics’s (INKT) Price Rate of Change (ROC) is -6.33, creating a Sell signal.

FAQ

Is INKT a Buy, Hold, or Sell?
Based on INKT’s technical indicators, INKT is a Sell.
    What is INKT’s RSI (14)?
    INKT’s RSI (14) is 35.88, which suggests INKT is a Neutral.
      What is INKT’s MACD?
      INKT’s MACD is -0.03, which suggests INKT is a Buy.
        What is INKT’s 5-day moving average?
        INKT’s 5-day moving average is 0.76, which suggests INKT is a Sell.
          What is INKT’s 20-day moving average?
          INKT 20-day moving average is 0.79, which suggests INKT is a Sell.
            What is INKT’s 50-day moving average?
            INKT’s 50-day moving average is 0.86, which suggests INKT is a Sell.
              What is INKT’s 200-day moving average?
              INKT’s 200-day moving average is 0.93, which suggests INKT is a Sell.
                What is INKT’s Williams % R (14)?
                INKT’s Williams % R (14) is -76.42, which suggests INKT is a Buy.
                  What is INKT’s CCI (14)?
                  INKT’s CCI (14) is -207.71, which suggests INKT is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis